Related Experiment Video
Updated: Jun 24, 2026
12:24
Helical Organization of Blood Coagulation Factor VIII on Lipid Nanotubes
Published on: June 3, 2014
Activation mechanisms of coagulation factor IX
Thomas Zögg1, Hans Brandstetter
1Department of Molecular Biology, Division of Structural Biology, University of Salzburg, Billrothstrasse 11, A-5020 Salzburg, Austria.
Biological Chemistry
|April 14, 2009
Summary
This study explores the complex blood clotting system, focusing on how factor IXa-factor VIIIa (Xase) functions uniquely. Superactive factor IX mutants offer insights into haemostasis and bleeding disorders like haemophilia.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Blood haemostasis relies on balanced coagulation and fibrinolytic processes.
- Imbalances lead to bleeding disorders like haemophilia A and B, caused by defects in factors VIII and IX.
- Understanding these complex pathways is crucial for treating bleeding disorders.
Purpose of the Study:
- To elucidate conserved principles across coagulation enzymes.
- To identify unique enzymatic properties of the factor IXa-factor VIIIa (Xase) system.
- To utilize superactive factor IX mutants for a better understanding of Xase action.
Main Methods:
- Comparative analysis of coagulation enzyme principles.
- Characterization of the factor IXa-factor VIIIa (Xase) system's enzymatic properties.
- Study of superactive factor IX mutants as models for Xase function.
Main Results:
- Identified conserved principles in coagulation enzymes.
- Highlighted distinct enzymatic characteristics of the Xase system.
- Demonstrated the utility of superactive factor IX mutants in studying Xase.
Conclusions:
- The Xase system possesses unique enzymatic properties within the coagulation cascade.
- Superactive factor IX mutants provide a valuable model for investigating Xase mechanisms.
- Further research into Xase modulation is essential for advancing haemostasis understanding.
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...